Amplitude (NASDAQ:AMPL) Updates FY 2025 Earnings Guidance

Key Points

• Amplitude has issued its FY 2025 earnings guidance, with an expected earnings per share of $0.040-0.08 and revenue guidance of $335.2 million-$338.2 million, both above consensus estimates.
• The stock price of Amplitude rose by 1.8% to reach $12.44, with a significant trading volume of 2,914,400 shares.
• Recent analyst reports show a range of adjustments in ratings, with the consensus rating at "Moderate Buy" and an average target price of $13.80.

Amplitude (NASDAQ:AMPL - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.040-0.08 for the period, compared to the consensus estimate of 0.079. The company issued revenue guidance of $335.2 million-$338.2 million, compared to the consensus revenue estimate of $330.9 million. Amplitude also updated its Q3 2025 guidance to -0.000-0.02 EPS.

Amplitude Price Performance

Shares of AMPL traded down $0.33 on Monday, reaching $11.20. 1,789,446 shares of the stock traded hands, compared to its average volume of 1,471,098. The firm has a market cap of $1.14 billion, a price-to-earnings ratio of -14.74 and a beta of 1.54. Amplitude has a 12 month low of $7.55 and a 12 month high of $14.88. The stock's 50-day moving average price is $12.39 and its 200-day moving average price is $11.56.

Amplitude (NASDAQ:AMPL - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.01 earnings per share for the quarter, meeting analysts' consensus estimates of $0.01. The firm had revenue of $83.27 million for the quarter, compared to analysts' expectations of $81.29 million. Amplitude had a negative return on equity of 33.08% and a negative net margin of 30.43%. Amplitude's revenue for the quarter was up 13.6% compared to the same quarter last year. As a group, equities research analysts forecast that Amplitude will post -0.62 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on AMPL shares. Wall Street Zen lowered Amplitude from a "buy" rating to a "hold" rating in a research report on Sunday, July 20th. Benchmark reiterated a "buy" rating on shares of Amplitude in a research note on Friday, July 11th. Robert W. Baird decreased their price objective on Amplitude from $17.00 to $14.00 and set an "outperform" rating on the stock in a report on Thursday, May 8th. DA Davidson cut their target price on Amplitude from $16.00 to $12.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Finally, Bank of America upped their target price on Amplitude from $13.00 to $15.00 and gave the company a "buy" rating in a research report on Monday, June 16th. Five research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Amplitude has an average rating of "Moderate Buy" and an average price target of $13.80.

Insider Buying and Selling at Amplitude

In related news, Director Catherine Wong sold 8,502 shares of the firm's stock in a transaction on Wednesday, June 11th. The stock was sold at an average price of $12.49, for a total value of $106,189.98. Following the transaction, the director directly owned 79,152 shares of the company's stock, valued at approximately $988,608.48. This trade represents a 9.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Erica Schultz sold 7,500 shares of the stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $12.56, for a total value of $94,200.00. Following the completion of the sale, the director owned 107,406 shares of the company's stock, valued at $1,349,019.36. The trade was a 6.53% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,911 shares of company stock worth $571,352. Company insiders own 4.80% of the company's stock.

Institutional Trading of Amplitude

Several institutional investors and hedge funds have recently modified their holdings of AMPL. Caxton Associates LLP purchased a new position in Amplitude in the first quarter worth $131,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Amplitude by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,399 shares of the company's stock valued at $473,000 after buying an additional 2,038 shares during the last quarter. NewEdge Advisors LLC purchased a new stake in shares of Amplitude during the first quarter valued at $580,000. Jones Financial Companies Lllp grew its holdings in shares of Amplitude by 93,569.0% during the first quarter. Jones Financial Companies Lllp now owns 93,669 shares of the company's stock valued at $954,000 after buying an additional 93,569 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Amplitude by 36.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 199,634 shares of the company's stock valued at $2,034,000 after purchasing an additional 53,791 shares during the last quarter. Institutional investors own 73.20% of the company's stock.

About Amplitude

Amplitude, Inc, together with its subsidiaries, provides a digital analytics platform that analyzes customer behavior in the United States and internationally. It offers Amplitude Analytics, which provides real-time product data and reconstructed user visits; Amplitude Experiment, a solution that allows teams to test new capabilities and safely roll out new features; Amplitude CDP, an insight-driven solution that encompasses the data infrastructure, audience management, and data streaming capabilities; and Amplitude Session Replay used by product, marketing, and data teams to understand user behavior, diagnose product issues, and improve product outcomes.